4.7 Review

Metal-Based Nanocatalyst for Combined Cancer Therapeutics

Journal

BIOCONJUGATE CHEMISTRY
Volume 31, Issue 5, Pages 1247-1258

Publisher

AMER CHEMICAL SOC
DOI: 10.1021/acs.bioconjchem.0c00194

Keywords

-

Funding

  1. Natural Science Foundation project [31971304, 21977024, 21601046]
  2. Natural Science Key Foundation of Hebei Province [B2017201226]
  3. Graduate Innovation Funding Project of Hebei Province [CXZZSS2018001]

Ask authors/readers for more resources

As a classical nanocatalyst-based therapeutic modality, chemodynamic therapy (CDT) has received more and more attention. To improve the therapeutic efficacy of CDT, various metal-based nanocatalysts have been designed and constructed to catalyze the Fenton or Fenton-like reaction in the past few years. However, the therapeutic efficacy of certain CDT is still restricted by the tumor microenvironment, such as limited concentration of intracellular H2O2, inappropriate pH condition, as well as overexpressed glutathione (GSH). Therefore, many other therapeutic modalities, such as photodynamic therapy (PDT), photothermal therapy (PTT), starvation therapy, chemotherapy, and gas therapy, have been utilized to combine with CDT for increasing the tumor treatment performance. In this review, we summarized the development of combinatory therapeutic modalities based on CDT in recent years.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available